The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale

Study summary

Early lung cancer screening (LCS) through low-dose computed tomography (LDCT) is crucial but underused due to various barriers, including incomplete or inaccurate patient smoking data in the electronic health record and limited time for shared decision-making. The objective of this trial is to investigate a patient-centered intervention, MyLungHealth, delivered through the patient portal. The intervention is designed to improve LCS rates through increased identification of eligible patients and informed decision making.

Ask AI to explain this study

Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedMyLungHealth and DecisionPrecision+

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 27, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of Utah

Study sponsor

Study overview

What this study is about

Purpose: Screening
Study type: Interventional
Phase: Not applicable
Sponsor: University of Utah
Interventions being studied: Behavioral: MyLungHealth; Behavioral: DecisionPrecision+

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Early-stage or resectable→

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

for both study 1 and study 2:
aged 50-79
a history of smoking (e.g., current or former tobacco use)
seen in a study primary care clinic in the 12 months preceding the start of the trial

Reasons someone may not be able to joinExclusion criteria

for both study 1 and study 2:
\>0 but \< 10 pack-year smoking history or quit more than 15 years ago
No use of the patient portal at least once in the year preceding the start of the study
A lung cancer diagnosis at the start of the study
LDCT completed in the past 3 years
Another chest CT completed in the past year
Structured EHR data indicating LCS SDM was provided in the past 3 years
Exposed to the intervention during the pilot phase
No visit at a study clinic during the trial period when the intervention was available Inclusion criteria for study 1:
a 10-19 pack-year smoking history, an unknown pack-year history, unknown quit date for patients who quit smoking, or a 0 pack-year smoking history Inclusion criteria for study 2:
at least a 20 pack-year smoking history and are a current smoker or have quit within the last 15 years

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

NYU Langone HealthNew York, New York
University of Utah HealthSalt Lake City, Utah

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 27, 2026. Always confirm current availability with the study team.

View original record ↗